Susanne Hallmeyer-Elgner
Overview
Explore the profile of Susanne Hallmeyer-Elgner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uckermann O, Galli R, Leupold S, Coras R, Meinhardt M, Hallmeyer-Elgner S, et al.
Epilepsia
. 2017 Jan;
58(1):e1-e5.
PMID: 28064458
The properties and structure of tissue can be visualized without labeling or preparation by multiphoton microscopy combining coherent anti-Stokes Raman scattering (CARS), addressing lipid content, second harmonic generation (SHG) showing...
2.
Hallmeyer-Elgner S
MMW Fortschr Med
. 2016 Jul;
153(14):58-63.
PMID: 27369837
No abstract available.
3.
Lojewski X, Srimasorn S, Rauh J, Francke S, Wobus M, Taylor V, et al.
Stem Cells Transl Med
. 2015 Aug;
4(10):1223-33.
PMID: 26304036
Unlabelled: Brain perivascular cells have recently been identified as a novel mesodermal cell type in the human brain. These cells reside in the perivascular niche and were shown to have...
4.
Karkoska A, Hallmeyer-Elgner S, Berth H, Reichmann H, Schmitz-Peiffer H
Epilepsy Behav
. 2015 Jan;
44:55-8.
PMID: 25622023
Objectives: The self-report of cognitive deficits by of patients with epilepsy is often poorly correlated with objective test performances but highly related to mood and personality. The aim of this...
5.
Lojewski X, Hermann A, Wegner F, Arauzo-Bravo M, Hallmeyer-Elgner S, Kirsch M, et al.
Stem Cells Transl Med
. 2014 Feb;
3(4):458-69.
PMID: 24558163
Adult neural progenitor cells (aNPC) are a potential autologous cell source for cell replacement in neurologic diseases or for cell-based gene therapy of neurometabolic diseases. Easy accessibility, long-term expandability, and...
6.
Bauer S, Hofbauer L, Rauner M, Strzelczyk A, Kellinghaus C, Hallmeyer-Elgner S, et al.
Epilepsy Res
. 2013 Aug;
106(3):417-22.
PMID: 23916144
Purpose: To determine early changes in bone turnover markers induced by treatment with oxcarbazepine or valproate. Methods: In this prospective study, 31 adults with newly diagnosed epilepsy were included who...
7.
Haehner A, Henkel S, Hopp P, Hallmeyer-Elgner S, Reuner U, Reichmann H, et al.
Epilepsy Behav
. 2012 Nov;
25(4):477-80.
PMID: 23153710
Objectives: The study aimed to assess olfactory function in patients with temporal lobe epilepsy before and after resection of temporal lobe structures and especially addressed the question whether there are...
8.
Hummel T, Henkel S, Negoias S, Galvan J, Bogdanov V, Hopp P, et al.
J Neurol
. 2012 Nov;
260(4):1004-8.
PMID: 23135292
The study aimed to investigate the volume of the olfactory bulb (OB) in patients with temporal lobe epilepsy (TLE). Specifically, we wanted to see whether the olfactory deficit typically found...
9.
Rosenow F, Schade-Brittinger C, Burchardi N, Bauer S, Klein K, Weber Y, et al.
J Neurol Neurosurg Psychiatry
. 2012 May;
83(11):1093-8.
PMID: 22595362
Background: Of the newer antiepileptic drugs, lamotrigine (LTG) and levetiracetam (LEV) are popular first choice drugs for epilepsy. The authors compared these drugs with regard to their efficacy and tolerability...
10.
Meisel C, Storch A, Hallmeyer-Elgner S, Bullmore E, Gross T
PLoS Comput Biol
. 2012 Jan;
8(1):e1002312.
PMID: 22241971
Critical dynamics are assumed to be an attractive mode for normal brain functioning as information processing and computational capabilities are found to be optimal in the critical state. Recent experimental...